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ABSTRACT  58 
A Swedish pedigree with an autosomal dominant inheritance of idiopathic 59 
scoliosis was initially studied by genetic linkage analysis, prioritising genomic 60 
regions for further analysis. This revealed a locus on chromosome 1 with a 61 
putative risk haplotype shared by all affected individuals.  62 
Two affected individuals were subsequently exome-sequenced, identifying a 63 
rare, non-synonymous variant in the CELSR2 gene. This variant is rs141489111, 64 
a c.G6859A change in exon 21 (NM_001408), leading to a predicted p.V2287I 65 
(NP_001399.1) change. This variant was found in all affected members of the 66 
pedigree, but showed reduced penetrance.  67 
Analysis of tagging variants in CELSR1-3 in a set of 1739 Swedish-Danish 68 
scoliosis cases and 1812 controls revealed significant association (p=0.0001) to 69 
rs2281894, a common synonymous variant in CELSR2. This association was not 70 
replicated in case-control cohorts from Japan and the US. No association was 71 
found to variants in CELSR1 or CELSR3.    72 
Our findings suggest a rare variant in CELSR2 as causative for idiopathic scoliosis 73 
in a family with dominant segregation and further highlight common variation in 74 
CELSR2 in general susceptibility to idiopathic scoliosis in the Swedish-Danish 75 
population. Both variants are located in the highly conserved GAIN protein 76 
domain, which is necessary for the auto-proteolysis of CELSR2, suggesting its 77 
functional importance.  78 
 79 
 80 
INTRODUCTION  81 
Idiopathic scoliosis is the most common spinal deformity manifesting in children 82 
and adolescents, and is characterised by an abnormal structural curvature of the 83 
spine. The prevalence of idiopathic scoliosis is approximately 2-3 % worldwide 84 
(1, 2). The cause of this disorder remains elusive, but studies on twins have 85 
shown a heritability of approx. 40%, indicating the importance of genetic factors 86 
(3).  87 
 88 
Genome wide association studies have identified several common genetic 89 
variants that modulate the susceptibility to this disorder (4-7) and linkage 90 
studies and exome sequencing in families with a high burden of idiopathic 91 
scoliosis have suggested some rare variants that modulate susceptibility to this 92 
disorder (8-13). The function of the associated genes/variants is in most cases 93 
unclear and their role in the pathogenesis of idiopathic scoliosis unknown. It is 94 
furthermore clear that much of the underlying genetic risk factors and 95 
mechanisms still remain to be identified.  96 
 97 
The aim of the current study was to identify the hypothesized single gene 98 
underlying an apparently dominant form of idiopathic scoliosis in a family from 99 
Sweden. An initial linkage analysis was combined with subsequent exome 100 
sequencing to enable prioritization of genome regions for risk variant search. 101 
Our analysis highlighted a rare non-synonymous variant in CELSR2 as a plausible 102 
idiopathic scoliosis risk variant. The identification of CELSR2 and understanding 103 
how it might contribute to the risk of idiopathic scoliosis may shed further light 104 
on the pathways and mechanisms involved in the pathogenesis of idiopathic 105 
scoliosis.  106 
 107 
 108 
MATERIAL & METHODS 109 
All studies were carried out in accordance with the relevant guidelines and 110 
regulations and all participating individuals gave their written informed consent. 111 
The Ethical Committee at Lund University (LU 200-95, LU 280-99, LU 363-02), 112 
the Regional Ethical Review Board in Stockholm (290/2006, 2009/1124-31/2, 113 
2012/1595-31/2) and Lund (567/2008, 2014/804), and the Regional 114 
Committees on Health Research Ethics for Southern Denmark (S-2011002) 115 
approved the study. 116 
 117 
Samples 118 
Swedish family 119 
A three-generation family (Fig 1) with a high burden of idiopathic scoliosis 120 
participated in the study.  All participating family members (n=15) were blood-121 
sampled and radiographed. All but one (I:II) were examined by a spine surgeon; 122 
however this individual had no scoliosis on radiographs. Individuals with a curve 123 
angle of 10 degrees or more, as measured by the Cobb method (14), were 124 
diagnosed with scoliosis. No one had any signs of a non-idiopathic scoliosis and 125 
all had an onset in adolescence, i.e. after the age of ten years (Supplementary 126 
table 1). DNA was extracted from blood either by a salt precipitation method on 127 
the Autopure LS system (Qiagen, Hilden, Germany) or the QIAamp 96 DNA blood 128 
kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions.  129 
 130 
Fig 1 -  The pedigree included in the current study.  131 
Affected individuals are indicated in black, unaffected in white. An obligate 132 
carrier of the chromosome 1 putative scoliosis risk haplotype (denoted by blue 133 
bars) is marked with a black dot. All numbered individuals have been genotyped 134 
and included in the linkage analysis. All putative non-risk haplotypes are 135 
denoted by white bars. The two exome-sequenced individuals are marked with 136 
asterisks. Carriers of the rare CELSR2 variant identified by exome sequencing are 137 
marked by a green box. 138 
 139 
 140 
Swedish-Danish case-control cohort 141 
The Swedish-Danish scoliosis case-control dataset consisted of 1739 individuals 142 
with idiopathic scoliosis (Scoliosis and Genetics in Scandinavia; ScoliGeneS) and 143 
1812 controls, described in more detail in (15). 144 
 145 
Japanese case-control cohort 146 
The Japanese case-control dataset consisted of 2,109 cases and 11,140 controls. 147 
Japanese AIS subjects were recruited from collaborating hospitals of the 148 
Japanese Scoliosis Clinical Research Group and were diagnosed through clinical 149 
and radiologic examinations by expert scoliosis surgeons. Control subjects were 150 
recruited from the BioBank Japan Project (https://biobankjp.org) and its related 151 
projects. It is described in more detail in (16). 152 
 153 
US case-control cohort 154 
The US case-control dataset consisted of an independent cohort of 9,312 155 
Caucasian subjects (1,360 cases and 7,952 controls). Case subjects were 156 
recruited at Texas Scottish Rite Hospital for Children in Dallas, Texas as 157 
previously described (6) and genotyped using Illumina HumanCoreExome 158 
Beadchip array. Informed consents were obtained from all research subjects. The 159 
study was approved by the Institutional Review Board of the University of Texas 160 
Southwestern Medical Center. For controls, we utilized a single dataset of 161 
individuals downloaded from the dbGaP web site (17) from the Geisinger Health 162 
System-MyCode, eMERGE III Exome Chip Study under phs000957.v1.p1 163 
(https://www.ncbi.nlm.nih.gov/projects/gap/cgi-164 
bin/study.cgi?study_id=phs000957.v1.p1). The dbGaP controls were previously 165 
genotyped on the same microarray platform used for cases. Only subjects self-166 
reported as Non-Hispanic White (NHW) were included in the present study. 167 
Phenotypes of all controls were reviewed to exclude any with associated 168 
musculoskeletal or neurological disorders. 169 
 170 
Family genotyping & linkage analysis  171 
1 ug of genomic DNA from each of the 15 participating family members was used 172 
at the SNP&SEQ genotyping facility in Uppsala, Sweden for genotyping on the 173 
Illumina HumanOmniExpressExome-8v1-2 array according to standard 174 
protocols (Illumina, San Diego, US) and the results were analyzed using the 175 
software GenomeStudio 2011.1 from Illumina. Two controls were also run in 176 
parallel. Genotyping was based on cluster files generated from the signal 177 
intensities from more than 800 DNA samples processed in parallel to this 178 
project. Samples with low (<95%) genotyping rate, markers with low (<99%) 179 
success rate, and monomorphic markers were removed. Markers with any 180 
inheritance errors within the pedigree, as assessed by Pedcheck (18) were 181 
removed from subsequent analysis.  182 
 183 
LD-based pruning of the genotype data was performed using the pairwise LD 184 
threshold function in PLINK (v1.07, www.pngu.mgh.harvard.edu/purcell/plink/, 185 
(19)), with a window of 50 markers, shifting by five markers at a time, and 186 
allowing the markers within each window to have an r2 of max 0.2 (--indep-187 
pairwise 50 5 0.2). The Rutgers genetic map interpolator (available at 188 
compgen4.rutgers.edu/mapinterpolator), based on the genetic map by Matise et 189 
al. (20), was used to attain genetic map information for the markers in the 190 
linkage analysis. The data (genotypes, pedigree information, phenotype 191 
information) was stored in BCGenome, a genome data integration platform from 192 
BC Platforms (Espoo, Finland). Merlin (v1.1.2, available at 193 
csg.sph.umich.edu/abecasis/Merlin/index.html, (21)) was used to perform non-194 
parametric linkage analysis, using the exponential model and assessing sharing 195 
of genetic regions between all affected individuals. Merlin was also used to 196 
predict the most likely haplotypes within the region of interest on chromosome 197 
1.  198 
 199 
Exome sequencing  200 
Two individuals, heterozygote carriers of the putative chromosome 1 risk 201 
haplotype, were chosen for exome sequencing. 120ng of genomic DNA was used 202 
to prepare AmpliSeq libraries run on Ion Torrent (Life Technologies, USA) 203 
sequencing according to standard protocols. The sequencing was performed at 204 
the Uppsala Genome Center, Uppsala, Sweden. The sequence reads were aligned 205 
to the hg19 genome reference assembly using the Ion Proton pipeline (Life 206 
Technologies, USA) and single nucleotide variants (SNVs) were identified in each 207 
sample using the Torrent Suite Software (Life Technologies, USA).  208 
 209 
The list of variants was filtered to retain only non-synonymous/splice/stop 210 
variants with a read depth of at least 10x. We also removed any variant with a 211 
frequency of 1% or higher in the 1000Genomes dataset (either all populations or 212 
Europeans, http://browser.1000genomes.org/, (22)) or the ExAC dataset (all 213 
populations or Europeans, exac.broadinstitute.org, (23)). 214 
 215 
Based on our linkage and haplotype analysis, we further limited our analysis to 216 
variants shared by both exome-sequenced individuals as heterozygous, and 217 
located within the linked region on chromosome 1 (GRCh37: 1:84,722,102-218 
113,819,478). Finally, the sequence quality underlying any such variants was 219 
manually assessed using the IGV browser (www.broadinstitute.org/igv/, (24)) to 220 
eliminate false-positive variant calls due to e.g. read-end artifacts.  221 
 222 
Bioinformatic analysis  223 
The tissue expression of any genes carrying putative candidate scoliosis risk 224 
variants was assessed through the FANTOM5 promoterome browser available at 225 
http://fantom.gsc.riken.jp/zenbu/, (25). The potential effects of the identified 226 
variant were assessed by looking at the SIFT (26), PolyPhen (27), MutTaster (28) 227 
and CADD {Kircher, 2014 #405} scores of each variant. The conservation of the 228 
variant was also assessed through the prediction of GERP-scores. These analyses 229 
were performed through the ANNOVAR pipeline (29).  230 
 231 
To analyse the effects of the p. V2287I mutation in CELSR2, we compared the 232 
predicted 3D structure of the protein either with a Valine (V) or Isoleucine (I) at 233 
position 2287 of the protein. We used the RaptorX tool (available at 234 
raptorx.uchicago.edu (30)) for 3D structure predictions with default parameters.  235 
 236 
Genotyping of the rare CELSR2 variant in a Swedish-Danish case cohort 237 
A Taqman assay C_166310564_10 from Life Technologies (Thermo Fisher, 238 
Waltham, US), following the manufacturer´s instructions, was used to assess the 239 
frequency of the rare CELSR2 variant, identified through exome sequencing of 240 
the family, in a previously described cohort of Swedish-Danish individuals with 241 
idiopathic scoliosis (15).  242 
 243 
Genotyping of common CELSR1, 2 and 3 variants in a Swedish-Danish case-control 244 
cohort 245 
The Agena (http://agenabio.com/, San Diego, US, previously Sequenom) 246 
MassARRAY® System, combined with iPLEX® chemistry, was used to genotype 247 
a set of common variants in CELSR1, 2 and 3. The variants were chosen using the 248 
LD TAG SNP Selection tool at https://snpinfo.niehs.nih.gov/snpinfo/snptag.php, 249 
(31)) to tag each gene with an LD threshold of r2=0.8. For practical reasons, only 250 
the variants fitting into two iPLEX pools were selected. The 20 common variants 251 
in CELSR1-3 were genotyped in the same cohort of Swedish-Danish cases and 252 
controls as used previously (15). The HWE of each marker in controls was 253 
assessed, and any sample with <80% call-rate was removed.  254 
 255 
Replication studies of associated CELSR2 variants 256 
The genotyping and imputation analysis in the Japanese cohort were carried out 257 
as previously described (16). 258 
 259 
In the US cohort, initial per-sample quality control measures were applied and 260 
we excluded sex inconsistencies and any with missing genotype rate per person 261 
more than 0.03. The remaining samples were merged using the default mode in 262 
PLINK.1.9 (32). Duplicated or related individuals were removed as described in 263 
(33). We used principal component analysis (PCA) (34) on the merged data 264 
projected onto HapMap3 samples as recommended by (35) to correct for 265 
possible stratification. We used PLINK for per-SNPs quality control including 266 
genotyping call-rate per marker (>95%) and deviation from Hardy-Weinberg 267 
equilibrium (cutoff p-value = 10-4). To check the association for common SNPs 268 
around the CELSR2 gene we performed genotype imputation using minimac3 269 
(36) with the 1000G-Phase3.V.5 reference panel as described in the instructions 270 
provided by the software developer available at 271 
(http://genome.sph.umich.edu/wiki/Minimac3_Imputation_Cookbook). Only 272 
common SNPs (MAF>0.05) with imputation quality r2 >0.3 were included for 273 
further analysis. Genetic association for the imputed allele dosages for the region 274 
around the CELSR2 gene (2Mb each side) was performed by Mach2dat software 275 
(37) using logistic regression with gender and ten principal components as 276 
covariates. 277 
 278 
RESULTS 279 
Identification of candidate genomic regions 280 
Fifteen family members (Fig 1) were genotyped using the Illumina 281 
HumanOmniExpressExome-8v1-2 array (genotyped individuals are marked with 282 
Roman numerals).  The average genotyping call rate, per SNP with sample call 283 
rate > 0, was >99%. The average call rate per sample was >99%. A set of 19,030 284 
pruned-in genetic markers with a 100% call rate was used for the subsequent 285 
non-parametric linkage analysis. Supplementary fig 1 shows the linkage for all 286 
chromosomes. The only region of the genome harboring an NPL linkage signal 287 
>1, indicating increased sharing of that chromosomal region by affected 288 
individuals, was at ca. 100-150 cM on chromosome 1 (Fig 2). This region thus 289 
emerged as the most plausible region harboring a putative scoliosis risk 290 
gene/variant, shared by the majority of affected family members.  291 
 292 
Fig 2 -  Genetic linkage peak on chromosome 1, indicating sharing in all 293 
affected individuals.  294 
The maximum K&C non-parametric LOD (NPL) score was attained through the 295 
exponential model. The x-axis shows the position on the chromosome (in cM), 296 
the y-axis shows the NPL score.   297 
 298 
We found that one haplotype co-segregated with idiopathic scoliosis in the 299 
pedigree, as shown in blue in Fig 1 (all other haplotypes are marked as white) 300 
and in further detail in Supplementary table 2. This putative risk haplotype was 301 
found in one copy in all affected individuals, as well as in unaffected individuals 302 
I:II, I:IV and II:VII as shown in Fig 1, and most likely explains the linkage signal 303 
we identified. Based on this analysis, the putative disease variant was 304 
hypothesized to lie between 84,8 -113,8 Mb (Genome Reference Consortium 305 
version 37, GRCh37), yielding a candidate region of circa 30Mb containing 306 
approx. 300 known genes. We restricted our subsequent search for scoliosis risk 307 
variants to this genomic region.  308 
 309 
Exome sequencing analysis & CELSR2  310 
We exome sequenced II:I and II:III, two members of the pedigree who shared one 311 
copy each of the putative risk haplotype on chromosome 1, in order to look for 312 
shared rare variants within the haplotype. We obtained >35M reads from each 313 
individual, with >95% on target and an average base coverage depth of >100,  314 
>98% of target bases covered at least 1x, and >57M bases in target regions.  315 
 316 
In total, 64,948 variants were called in the exome analysis; the full set of variants 317 
is available as Supplementary data 1. Of these, 40,818 were found in both 318 
individuals. 40,291 variants were autosomal, and 16,290 variants were 319 
exonic/affecting splice sites. Of these, 7162 variants were predicted to result in 320 
stop codon loss or gain, or non-synonymous changes and 61 of them were 321 
located within the region of linkage on chromosome 1. Filtering by frequency 322 
(allowing <1% minor allele frequency in 1000Genomes ALL/EUR or ExAC 323 
ALL/EUR), only three variants remained. Two of these variants were further 324 
excluded as being highly likely technical artifacts (Supplementary fig 3).  325 
 326 
The final filtered list of high-quality non-synonymous variants within the linkage 327 
region on chromosome 1 thus consisted of only one single-nucleotide variant. 328 
This finding was confirmed by Sanger sequencing (Supplementary fig 4 shows 329 
individual I:III (wildtype) and I:I (heterozygote carrier)). This variant was 330 
rs141489111, a non-synonymous variant resulting in a c.G6859A (NM_001408) 331 
change in exon 21 of the cadherin EGF lag seven-pass G-type receptor 2 (CELSR2) 332 
gene. Rs141489111 is predicted to result in a p.V2287I (NP_001399.1) change in 333 
the protein. 334 
This variant was found on the genotyping array used for the initial linkage 335 
analysis. The co-segregation of this variant and the chromosome 1 risk haplotype 336 
with scoliosis within the entire pedigree could thus be assessed (green boxes in 337 
Fig 1). 338 
 339 
The A allele of rs141489111 is rare; it is not found in any of the 1000 Genomes 340 
populations and it has a frequency of only 0.22% in the NHLBI-ESP European 341 
American Cohort (http://evs.gs.washington.edu/EVS/, Exome Variant Server, 342 
NHLBI GO Exome Sequencing Project (ESP), Seattle, WA, accessed 26.01.2017). It 343 
has a frequency of 0.1477% in the ExAC (http://exac.broadinstitute.org/, 344 
accessed 03.07.2017) non-Finnish European population, and 0.086% in the 345 
whole dataset. The frequency of this variant in the GnomAD database 346 
(http://gnomad.broadinstitute.org/, accessed 03.07.2017) is 0.1643% in non-347 
Finnish Europeans and 0.089% in the whole dataset. The putative p.V2287I 348 
change replaces a hydrophobic side chain by a larger one.  The SIFT and 349 
MutTaster scores (1 and 0.96, respectively) do not argue for this variant being 350 
directly damaging to the CELSR2 protein, whereas the PolyPhen score of 0.36 is 351 
more indeterminate and the CADD score of 22 indicates that this variant might 352 
be damaging. The rs141489111 GERP score of 4.06 indicates considerable 353 
conservation of this amino acid, arguing for a functional restraint on its function. 354 
Supplementary fig 5 shows clustalX alignments (available at www.uniprot.org) 355 
of the amino acids 2261-2320 of Q9HCU4 (human CELSR2) compared to those of 356 
several other vertebrate animals. Position 2287 in the human CELSR2 is marked 357 
in red. This position is strongly conserved, as well as the adjacent region. 358 
 359 
The V2287I variant is located within the ancient and highly conserved GAIN 360 
domain (38) (Fig 3). Fig 4 shows the predicted three-dimensional structure of 361 
the GAIN domain of CELSR2 (pdb-files available on demand). While the V2287I 362 
change is not expected to have major effects on the structure of the protein, the 363 
predicted structure of CELSR2 indicates that it is located in close proximity to the 364 
H2355-T2357 autoproteolysis cut site (38).  365 
 366 
Fig 3 - Schematic of the structure of the CELSR2 protein.  367 
Shown are  the cadherin, EGF-like, and laminin-G-like domains. Also the 368 
transmembrane  (TM) 7-pass domain and the evolutionarily conserved GAIN 369 
domain. The GAIN domain contains within it a GPS domain and is the site of 370 
autoproteolytic cleavage of CELSR2. The rare V2287I variant and more common 371 
R2060R tagging variant are both located within the GAIN domain. 372 
 373 
Fig 4 -Visualisation of the predicted structure of the GAIN domain of 374 
CELSR2.  375 
The left panel shows the wildtype 2287V form, the right panel shows the 376 
mutated 2287I form. The location of the V2287I and R2060R variants are shown, 377 
as well as the site of autoproteolytic cleavage.   378 
 379 
 380 
Genotyping of rare CELSR2 variant in an independent cohort 381 
1737 Swedish individuals with idiopathic scoliosis (15) were successfully 382 
genotyped for the CELSR2 rs141489111 variant (genotyping success rate of 383 
>99%). We identified five independent carriers of the rs141489111 variant, 384 
including the proband of the Swedish large family. This equates to an allele 385 
frequency of 0.1439% in this case cohort. We found no indication that the four 386 
carriers were directly related to the family under study or to each other (data not 387 
shown). 388 
 389 
Genotyping of common CELSR1-3 variants in an independent cohort 390 
To further investigate CELSR2 and its related genes CELSR1 and CELSR3, we 391 
selected a set of twenty common tagging variants within these genes. Removing 392 
any samples with a genotyping success rate <80% yielded data for 1731 cases 393 
and 1783 controls. 394 
 395 
No significant association was found to any of the variants in CELSR1 or CELSR3, 396 
but two variants in CELSR2 showed significant association at the p<0.05 level 397 
(Table 1 and Supplementary fig 6). The C allele of the CELSR2 rs6698843 variant 398 
was overrepresented in cases (0.571 vs. 0.546), p=0.0398, OR 1.10 (not 399 
significant after Bonferroni-correction for multiple testing). This variant results 400 
in a predicted synonymous P1712P in one of the EGF-like domains of CELSR2, as 401 
shown in Fig 3 and 4. The A allele of the CELSR2 rs2281894 variant had a 402 
frequency of 0.225 in cases versus 0.188 in controls (p=0.0001, OR 1.25 403 
(Bonferroni-corrected p=0.002)).  The more strongly associated variant 404 
rs2281894 represents a predicted synonymous R2060R within the GAIN domain 405 
of the CELSR2 protein (Figs 3 and 4). These two markers are neither in linkage 406 
disequilibrium with each other nor with the rare rs141489111 variant identified 407 
in the large family (data not shown).   408 
 409 
TABLE 1. Association of tagging variants in CELSR1, 2 and 3 to idiopathic 410 
scoliosis in a set of Swedish cases and controls.  411 
 412 
GENE Chr Name b38 pos Assoc Allele Case,Control Counts Case,Control Freq P value OR (95% CI) 
CELSR1 22 rs35364389 46364189 T 544:2904, 550:3026 0.158, 0.154 0.6465   
CELSR1 22 rs9615351 46364584 G 837:2611, 858:2708 0.243, 0.241 0.8339   
CELSR1 22 rs6007897 46384624 C 552:2912, 542:3030 0.159, 0.152 0.3780   
CELSR1 22 rs6008794 46391797 G 546:2910, 547:3025 0.158, 0.153 0.5748   
CELSR1 22 rs6008813 46416688 A 861:2597, 867:2711 0.249, 0.242 0.5156   
CELSR1 22 rs4823549 46468568 G 1890:1568, 1929:1645 0.547, 0.540 0.5656   
CELSR1 22 rs4823554 46475875 C 2392:1038, 2462:1102 0.697, 0.691 0.5506   
CELSR1 22 rs9627484 46512158 G 1116:2348, 1150:2428 0.322, 0.321 0.9454   
CELSR1 22 rs4823849 46530585 A 2120:1328, 2169:1397 0.615, 0.608 0.5705   
CELSR1 22 rs4823561 46533795 A 235:3229, 242:3336 0.068, 0.068 0.9727   
CELSR1 22 rs4823850 46535180 G 237:3207, 233:3337 0.069, 0.065 0.5523   
                  
CELSR2 1 rs413380 109252404 T 115:3337, 118:3456 0.033, 0.033 0.9444   
CELSR2 1 rs10858082 109256099 G 1583:1869, 1587:1979 0.459, 0.445 0.2546   
CELSR2 1 rs653635 109263691 T 3105:353, 3196:376 0.898, 0.895 0.6618   
CELSR2 1 rs6698843 109264212 C 1965:1479, 1941:1613 0.571, 0.546 0.0398 1.10 (1.00-1.21) 
CELSR2 1 rs2281894 109267922 A 780:2682, 671:2895 0.225, 0.188 0.0001 1.25 (1.12-1.41) 
CELSR2 1 rs4970834 109272258 C 2817:627, 2888:676 0.818, 0.810 0.4125   
CELSR2 1 rs629301 109275684 T 2691:763, 2746:828 0.779, 0.768 0.2808   
                  
CELSR3 3 rs12107252 48653883 T 3053:407, 3153:425 0.882, 0.881 0.8811   
CELSR3 3 rs3821875 48660221 C 3064:396, 3164:410 0.886, 0.885 0.9720   
The name of each marker, position (build 38), the allele counts and allele 413 
frequencies are shown. Also the P-values as well as the odds ratio (OR) and 95% 414 
confidence interval (CI) for markers with P-values < 0.05.  All P-values are 415 
uncorrected.  416 
 417 
 418 
Replication study of common CELSR2 variants 419 
The two common variants in CELSR2 that showed significant association to 420 
idiopathic scoliosis in the Swedish-Danish population, rs6698843 and 421 
rs2281894, were further tested for association in two additional case-control 422 
datasets. In a genome-wide association study (GWAS) dataset from Japan 423 
(previously described in detail in (16)), neither marker showed association to 424 
idiopathic scoliosis.  Rs6698843 had a p-value of 0.61 and an OR of 0.98; 425 
rs2281894 had a p-value of 0.95 and an OR of 1.00. Results from the US cohort 426 
did not show association with idiopathic scoliosis for the two common CELSR2 427 
variants (rs6698843_p-value = 0.839 (OR = 1.01); rs2281894_p-value = 0.465 428 
(OR = 0.96).  429 
 430 
 431 
DISCUSSION 432 
Idiopathic scoliosis has proven to be a complex disorder with high genetic 433 
heterogeneity. By linkage analysis and exome sequencing of a family with a high 434 
burden of idiopathic scoliosis we identified a rare missense mutation in the 435 
highly conserved CELSR2 gene. We suggest a novel causative mechanism in the 436 
aetiology of idiopathic scoliosis. 437 
 438 
The rare CELSR2 variant co-segregating with idiopathic scoliosis in the pedigree 439 
under study is a previously described variant with a frequency of approx. 0.08-440 
0.16% in the general European population. The position of the rare CELSR2 441 
rs141489111 variant, as well as the G-protein coupled receptor (GPCR) auto-442 
proteolysis-inducing (GAIN) domain within which it is situated, is strongly 443 
conserved throughout evolution, arguing for the functional importance of this 444 
protein. Upon genotyping of a large cohort of independent Swedish-Danish 445 
idiopathic scoliosis patients, we did not find an elevated prevalence. This variant 446 
does thus not alone explain a significant part of idiopathic scoliosis susceptibility 447 
at the population level, while it remains a plausible candidate for rare, 448 
monogenic forms of scoliosis.  449 
 450 
In order to further understand the possible importance of CELSR2 in idiopathic 451 
scoliosis, we genotyped common variants within CELSR2 and the related genes 452 
CELSR1 and 3, in a large independent case-control cohort. Interestingly enough, 453 
we found an association of idiopathic scoliosis to another variant, rs2281894, 454 
also situated in the GAIN domain of CELSR2. This association could not be 455 
replicated in large cohorts of Japanese and US case-control datasets. It remains 456 
unknown if this is due to differences in diagnostic criteria/selection of samples 457 
or perhaps due to population differences in the underlying genetic risk factors. 458 
Future studies, aiming to dissect in further detail the overall importance of the 459 
CELSR1-3/associated genes contribution to scoliosis in multiple populations will 460 
be undertaken to understand this further. 461 
 462 
CELSR2 is highly expressed in neuronal tissues, including adult temporal lobe, 463 
occipital pole and postcentral gyrus, in addition to whole brain, neurons and fetal 464 
and adult spinal chord (as assessed through FANTOM5). In CELSR2-deficient 465 
mice, the development and planar organization of ependymal cilia are 466 
compromised, leading to fatal hydrocephalus (39). Compound heterozygosity for 467 
mutations in CELSR2 have recently been suggested to cause Joubert syndrome, a 468 
ciliopathy disorder, in a young girl (40). This girl showed a phenotype of cortical 469 
heterotopia, microophthalmia, severe growth retardation, cone-shaped 470 
epiphyses and growth hormone deficiency. This phenotype is obviously more 471 
severe than idiopathic scoliosis and supports the notion that a drastic change in 472 
the function of CELSR2 would likely be lethal or cause a more severe phenotype 473 
than idiopathic scoliosis. Furthermore, the penetrance of scoliosis in carriers of 474 
the CELSR2 variant in the present study is incomplete, suggesting additional 475 
unknown modifiers of disease risk (genetic or environmental). 476 
 477 
The cellular function of CELSR2 is not fully understood but it is known to be 478 
important for axon guidance, neuronal migration, and cilium polarity (41-43). 479 
CELSR2 is located at the plasma membrane and belongs to the flamingo cadherin 480 
subfamily (39)). This group of proteins is involved in contact-mediated 481 
communication between cells and consists of a large extra-cellular domain, a 482 
seven-pass transmembrane domain and a cytoplasmic tail (44). The rare variant 483 
identified in the family induces a change from valine to isoleucine in the 484 
extracellular part of the protein, in the so-called GAIN domain. The GAIN domain 485 
is required and necessary for autoproteolysis of the protein (38), and while the 486 
result of changing this particular valine to an isoleucine remains unclear, it is 487 
plausible to suggest a possible effect on this mechanism. 488 
 489 
In conclusion, we have identified CELSR2 as a putative novel risk gene idiopathic 490 
scoliosis, and we hypothesise that this effect may be mediated through a 491 
disruption of the auto-proteolytic mechanism of the GAIN domain in the CELSR2.  492 
Future studies will focus on functional studies to understand the specific 493 
mechanisms underlying this disruption. 494 
 495 
 496 
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SUPPLEMENTARY FILE LEGENDS 536 
Supplementary fig 1. Merlin NPL pruned linkage plots. Plots per 537 
chromosome, using the linear (black) or exponential (blue) functions.  538 
The x-axis indicates position on the chromosome in cM, the y-axis indicates the 539 
non-parametric LOD score. Data for “ALL” (sharing between all affected) or 540 
“Pairs” (sharing between all possible pairs of affected) is shown.  541 
 542 
Supplementary fig 2. Ion Torrent pipeline output. The output QC for the 543 
exome sequencing of individuals II:I (up101_1) and II:III (up101_2).  544 
 545 
Supplementary fig 3. A, B, C  Screenshot from IGV browser. 546 
(software.broadinstitute.org/software/igv/), Figure shows the three putative 547 
rare CELSR2 variants shared by both sequenced individuals (upper: II:I, lower: 548 
II:III). Panel A shows a putative 1:109805856, C>T variant, panel B shows a 549 
putative 1:109805857, C>G variant. Both reside within the same region of low 550 
quality sequence and were deemed to be false positive variant calls. Panel C 551 
shows the 1:109812092, G>A variant, confirmed by Sanger sequencing to be a 552 
true variant.  553 
 554 
Supplementary fig 4. Sanger validation. 555 
CELSR2 1:109812092, G>A variant shown by Sanger sequencing. Upper panel 556 
shows the wildtype G/G genotype (in I:III), lower panel shows an A/G 557 
heterozygote (I:I).  558 
 559 
Supplementary fig 5. CELSR2 conservation.  560 
Conservation of the CELSR2 protein between humans (HUMAN), mice (MOUSE), 561 
rat (RAT), dog (CANLF), CAVPO (guinea pig), OTOGA (small-eared galago), 562 
BOVIN (bovine), AILME (giant panda), and rabbit (RABIT). The location of the 563 
human V2287 is marked in red.  564 
 565 
Supplementary fig 6. Tagging variants. 566 
Association of tagging variants in CELSR2 with idiopathic scoliosis in a Swedish 567 
case-control dataset. The plot is produced using LocusZoom, available at 568 
locuszoom.org. The x-axis shows the position of the variants on the chromosome 569 
(in Mb), and relative to CELSR2 and neighbouring genes. The left y-axis shows 570 
the -log of the association. The most strongly associated variant, rs2281894, is 571 
marked with a diamond; the colour of the other markers (circles) is determined 572 
by their linkage disequilibrium (LD) with rs228194 (based on 573 
hg19/1000Genomes Nov2014 EUR). The right y-axis shows the recombination 574 
rate in the region as a light blue line.  575 
 576 
Supplementary table 1. Phenotypes. 577 
Phenotypic information on the family members included in the linkage/exome 578 
sequencing analysis. Individual numbering is as in Fig 1.  579 
 580 
Supplementary table 2. Haplotypes. 581 
Chromosome 1 Merlin most probable haplotypes flow (haplotypes coded as A, B, 582 
C etc, and colour coded for simplicity). Haplotypes are produced using Merlin, 583 
according to the most likely pattern of gene flow (--best) and using the -- 584 
horizontal flag.  585 
 586 
Supplementary dataset 1   587 
All exonic variants in II:I and II:III. Compressed variant list, annotated by 588 
Annovar, containing all the exonic variants found in either II:I or II:III (or both).  589 
 590 
 591 
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